CYP19A1 and hyperinsulinemic hypoglycemia, familial, 4: A Evidence from both human genetics and animal models has shown that disruption of estrogen signaling—such as through aromatase or estrogen receptor α deficiency—can lead to marked metabolic dysfunction (38).